Colchicine and macrolides: a cohort study of the risk of adverse outcomes associated with concomitant exposure

Colchicine is increasingly used as the number of potential indications expands. However, it also has a narrow therapeutic index that is associated with bothersome to severe side effects. When concomitantly use with medications inhibiting its metabolism, higher plasma levels will result and increase...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Malinda S., Gomez-Lumbreras, Ainhoa, Villa-Zapata, Lorenzo, Malone, Daniel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Pharmacovigilance
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473467/
https://www.ncbi.nlm.nih.gov/pubmed/36104598
http://dx.doi.org/10.1007/s00296-022-05201-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9473467/
https://www.ncbi.nlm.nih.gov/pubmed/36104598
http://dx.doi.org/10.1007/s00296-022-05201-5

Ejemplares similares